J 2022

Metabolic tricks of cancer cells

HÖNIGOVÁ, Kateřina, Jiří NAVRÁTIL, Barbora PELTANOVÁ, Hana HOLCOVÁ POLANSKÁ, Martina RAUDENSKÁ et. al.

Basic information

Original name

Metabolic tricks of cancer cells

Authors

HÖNIGOVÁ, Kateřina (203 Czech Republic, belonging to the institution), Jiří NAVRÁTIL (203 Czech Republic, belonging to the institution), Barbora PELTANOVÁ (203 Czech Republic, belonging to the institution), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Martina RAUDENSKÁ (203 Czech Republic, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, belonging to the institution)

Edition

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Amsterdam, Elsevier, 2022, 0304-419X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 11.200

RIV identification code

RIV/00216224:14110/22:00125657

Organization unit

Faculty of Medicine

UT WoS

000806557500001

Keywords in English

Cancer metabolism; ;Warburg effect; Glutaminolysis; Mitochondrial bioenergetics; Metabolic symbiosis; Cell death

Tags

International impact, Reviewed
Změněno: 19/7/2022 10:25, Mgr. Tereza Miškechová

Abstract

V originále

One of the characteristics of cancer cells important for tumorigenesis is their metabolic plasticity. Indeed, in various stress conditions, cancer cells can reshape their metabolic pathways to support the increased energy request due to continuous growth and rapid proliferation. Moreover, selective pressures in the tumor microenvironment, such as hypoxia, acidosis, and competition for resources, force cancer cells to adapt by complete reorganization of their metabolism. In this review, we highlight the characteristics of cancer metabolism and discuss its clinical significance, since overcoming metabolic plasticity of cancer cells is a key objective of modern cancer therapeutics and a better understanding of metabolic reprogramming may lead to the identification of possible targets for cancer therapy.

Links

FW03010186, research and development project
Name: Nová biočipová a mikrofluidní diagnostika cirkulujících biomarkerů a farmakogenů u psychiatrických a onkologických onemocnění
Investor: Technology Agency of the Czech Republic, Subprograms 1 Technology leaders
GA21-06873S, research and development project
Name: Metabolická symbióza mezi nádorovými buňkami a fibroblasty asociovaných s nádorem u nádorů v oblasti hlavy a krku
Investor: Czech Science Foundation
MUNI/A/1391/2021, interní kód MU
Name: Molekulární, buněčná, tkáňová a systémová patofyziologie vybraných komplexních nemocí (Acronym: KOMPLEX_PF)
Investor: Masaryk University
NU21-03-00223, research and development project
Name: Vliv metabolického reprogramování fibroblastů asociovaných s nádorem na prognózu pacientů s nádory hlavy a krku
Investor: Ministry of Health of the CR, Subprogram 1 - standard